Fungal Keratitis Treatment Market Size

Fungal Keratitis Treatment Market was valued at USD 875.4 million in 2023 and is anticipated to experience growth at a CAGR of 6.1% from 2024 to 2032 driven by increasing incidence of eye infections and growing geriatric population.

For instance, according to the World Health Organization, by 2031, 1 in 6 people will be aged 60 years and above all over the globe. With the global population aging rapidly, particularly in developed countries, there is a parallel increase in the prevalence of age-related eye conditions, including fungal keratitis. Thus, this demographic trend significantly drives the demand for fungal keratitis treatment. Furthermore, advances in research and development activities contribute to the discovery of novel antifungal drugs, drug delivery systems, diagnostic tools, and therapeutic approaches for fungal keratitis treatment, thereby propelling the growth of this market.

Fungal keratitis is a serious eye infection caused by various types of fungi. It typically occurs when fungi invade the cornea, the clear dome-shaped surface that covers the front of the eye. Fungal keratitis can result from injury to the eye, prolonged use of contact lenses, or from fungal spores present in the environment. Fungal keratitis treatment refers to the management and therapeutic interventions employed to address fungal keratitis. It involves various approaches aimed at eliminating the fungal infection, reducing inflammation, and promoting healing of the affected cornea.